NIH Deputy Director and NIAID infectious disease physician Matthew Memoli explains the new research protocol (sometimes called a “vaccine injury clinic”) to board chair Jack Leslie, a senior advisor at the PR firm Weber Shandwick which represents most of the world’s vaccine companies. Memoli describes it as a new NIAID research project studying people who report long-term symptoms after vaccination and after infections (post-infectious syndromes such as those seen with Lyme, flu, long COVID, and others). He argues the goal is to diagnose, understand, and find ways to treat these patients so their lives improve—regardless of whether the trigger was a vaccine or an infection. He notes that in many cases (especially COVID), the symptoms can be nearly identical and hard to distinguish.
If you would like to receive an e-mail notice of the most recent articles published in The Vaccine Reaction each week, click here.












